Christopher Rex
Fundador en Afraxis, Inc. .
Cargos activos de Christopher Rex
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/2010 | - |
| Fundador | 01/01/2010 | - |
Historial de carrera de Christopher Rex
Antiguos cargos conocidos de Christopher Rex.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
T123 LLC
 T123 LLC Investment ManagersFinance I2020 Accelerator (I2020 Accelerator) is a venture capital firm founded in 2018. The firm is headquartered in San Diego, California. | Director/Miembro de la Junta | 01/09/2018 | 01/04/2021 |
Formación de Christopher Rex.
| University of California, Irvine | Doctorate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Afraxis, Inc.
Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Health Technology |
T123 LLC
T123 LLC Investment ManagersFinance I2020 Accelerator (I2020 Accelerator) is a venture capital firm founded in 2018. The firm is headquartered in San Diego, California. | Finance |
- Bolsa de valores
- Insiders
- Christopher Rex
- Experiencia